Scarica l'app Stockscreener
2.76
2.71%
0.18
Precedente Chiudi:
$2.58
Aprire:
$2.6084
Volume 24 ore:
1,021
Relative Volume:
0.06
Capitalizzazione di mercato:
$106.27M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-1.0954
EPS:
-2.5197
Flusso di cassa netto:
-
1 W Prestazione:
-18.96%
1M Prestazione:
+35.90%
6M Prestazione:
-79.22%
1 anno Prestazione:
-73.99%
Intervallo 1D:
$2.6084
$2.6084
Intervallo di 1 settimana:
$2.50
$3.44
Portata 52W:
$1.85
$17.48
Adlai Nortye Ltd Adr Stock (ANL) Company Profile
Nome
Adlai Nortye Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta ANL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| ANL | 2.6084 | 106.27M | 0 | 0 | 0 | -2.5197 |
| VRTX | 447.18 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 741.71 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 589.39 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.84 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 103.36 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Adlai Nortye Ltd Adr Borsa (ANL) Ultime notizie
Adlai Nortye shares hold Buy rating by H.C. Wainwright on oncology programs - Investing.com
Adlai Nortye stock strengthened by oncology trial results, H.C. Wainwright keeps at Buy list - Investing.com
ANL stock touches 52-week low at $1.85 amid sharp annual decline - Investing.com
ANL stock touches 52-week low at $1.85 amid sharp annual decline By Investing.com - Investing.com South Africa
Adlai Nortye stock plunges to 52-week low of $1.89 - Investing.com
Adlai Nortye stock plunges to 52-week low of $1.89 By Investing.com - Investing.com Canada
Adlai Nortye Ltd. Sponsored ADR (ANL) Loses -33.06% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
H.C. Wainwright sees upside in Adlai Nortye stock amid robust oncology pipeline - Investing.com
Adlai Nortye Reports Strong 2024 Mid-Year Results - TipRanks
Adlai Nortye releases unaudited H1 2024 results, adds new director - Investing.com
Adlai Nortye Announces Executive Leadership Transition - TipRanks
Closing Bell Recap: Adlai Nortye Ltd. ADR (ANL) Ends at 7.70, Reflecting a -6.78 Downturn – DWinneX - The Dwinnex
Adlai Nortye to Unveil Cancer Drug Data at ASCO 2024TipRanks.com - TipRanks
Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024 - GlobeNewswire Inc.
Are Medical Stocks Lagging Adlai Nortye Ltd. Sponsored ADR (ANL) This Year? - Yahoo Finance Australia
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Markets Insider
symbol__ Stock Quote Price and Forecast - CNN
Adlai Nortye (ANL) Stock Price, News & Analysis - MarketBeat
IPO Update: Adlai Nortye Readies $72 Million U.S. IPO (Pending:ANL) - Seeking Alpha
Adlai Nortye Ltd Adr Azioni (ANL) Dati Finanziari
Non sono disponibili dati finanziari per Adlai Nortye Ltd Adr (ANL). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.42%
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):